Russia may restrict drug imports from Western countries

11 August 2014
moscow-big

The Russian Federation Council, the upper house of theFederal Assembly of the country, has put forward a proposal to restrict imports of drugs from Western countries to Russia, in response to sanctions, imposed on the country by the USA and the European Union, reports The Pharma Letter’s Russia correspondent.

According to Nikolay Zhuravlev, deputy chairman of the Council’s Committee on Budget and Financial Markets, there is a need to ban imports of over-the-counter (OTC) drugs from Western countries that have Russian analogues.

At the same time such a proposal has already sparked criticism from some Russian analysts in the pharmaceutical business field, according to whom Russian patients will be forced to switch to local generics and toxic substitutes of original drugs. Earlier, cheap generics have already replaced high-quality original drugs in a list of drugs which are purchased by the government for state needs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical